These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7917773

  • 1. Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.
    Holford NH, Guentert TW, Dingemanse J, Kettler R.
    Br J Clin Pharmacol; 1994 Jun; 37(6):553-7. PubMed ID: 7917773
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
    Henriot S, Kuhn C, Kettler R, Da Prada M.
    J Neural Transm Suppl; 1994 Jun; 41():321-5. PubMed ID: 7931245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
    Bench CJ, Price GW, Lammertsma AA, Cremer JC, Luthra SK, Turton D, Dolan RJ, Kettler R, Dingemanse J, Da Prada M.
    Eur J Clin Pharmacol; 1991 Jun; 40(2):169-73. PubMed ID: 1906004
    [Abstract] [Full Text] [Related]

  • 8. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
    Dingemanse J, Hussain Y, Korn A.
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
    [Abstract] [Full Text] [Related]

  • 9. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
    Kettler R, Cesura AM, Dingemanse J, Da Prada M.
    J Neural Transm Suppl; 1990 Apr; 32():211-4. PubMed ID: 2089093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tolerability, safety, pharmacodynamics, and pharmacokinetics of rasagiline: a potent, selective, and irreversible monoamine oxidase type B inhibitor.
    Thébault JJ, Guillaume M, Levy R.
    Pharmacotherapy; 2004 Oct 10; 24(10):1295-305. PubMed ID: 15628826
    [Abstract] [Full Text] [Related]

  • 17. Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation.
    Berlin I, Aubin HJ, Pedarriosse AM, Rames A, Lancrenon S, Lagrue G, Lazabemide in Smoking Cessation Study Investigators.
    Addiction; 2002 Oct 10; 97(10):1347-54. PubMed ID: 12359039
    [Abstract] [Full Text] [Related]

  • 18. The density of monoamine oxidase B sites is not altered in the postmortem brain of alcoholics.
    Maeztu AI, Ballesteros J, Callado LF, Gutiérrez M, Meana JJ.
    Alcohol Clin Exp Res; 1997 Nov 10; 21(8):1479-83. PubMed ID: 9394121
    [Abstract] [Full Text] [Related]

  • 19. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers.
    Hinze C, Harland D, Zreika M, Dulery B, Hardenberg J.
    J Neural Transm Suppl; 1990 Feb 27; 32():203-9. PubMed ID: 2089092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.